KDM5A-IN-1

KDM5A-IN-1 Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: MedChemexpress LLC  
Tel: 021-58955995
Email: sales@medchemexpress.cn
Company Name: Sichuan Wei Keqi Biological Technology Co., Ltd.  
Tel: 028-81700200 18116577057
Email: 3003855609@qq.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com

KDM5A-IN-1 manufacturers

  • KDM5A-IN-1
  • KDM5A-IN-1 pictures
  • $149.00
  • 2026-07-14
  • CAS:1905481-36-8
  • Purity: 100.00%
  • Supply Ability: 10g
KDM5A-IN-1 Basic information
Product Name:KDM5A-IN-1
Synonyms:KDM5A-IN-1;KDM5A inhibitor 1;Cyclopropanecarboxamide, N-[(3R)-1-[[5-(1-methylethyl)-1H-pyrazol-3-yl]carbonyl]-3-pyrrolidinyl]-;KDM5A IN 1,KDM5AIN1,KDM-5A-IN-1;KDM5A-IN-1, 10 mM in DMSO
CAS:1905481-36-8
MF:C15H22N4O2
MW:290.36
EINECS:
Product Categories:
Mol File:1905481-36-8.mol
KDM5A-IN-1 Structure
KDM5A-IN-1 Chemical Properties
Boiling point 592.6±50.0 °C(Predicted)
density 1.25±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : ≥ 50 mg/mL (172.20 mM)
form Solid
pka12.68±0.10(Predicted)
color White to off-white
Safety Information
MSDS Information
KDM5A-IN-1 Usage And Synthesis
UsesKDM5A-IN-1 is a potent, orally bioavailable pan-histone lysine demethylases 5 (KDM5) inhibitor with IC50s of 45 nM, 56 nM and 55 nM for KDM5A, KDM5B and KDM5C, respectively, and with an EC50 value of 960 nM for PC9 H3K4Me3. KDM5A-IN-1 is significantly less potent against other KDM5B enzymes (1A, 2B, 3B, 4C, 6A, 7B)[1].
in vivo

KDM5A-IN-1 (Compound 50, 5 mg/kg; oral administration; female CD-1 mice) treatment shows moderate clearance (28 mL/min/kg) in mice with good oral bioavailability (F% 34) and remarkably low plasma protein binding in mice (40%), with t1/2 of 0.4 hours[1].

Animal Model:Female CD-1 mice[1]
Dosage:5 mg/kg
Administration:Oral administration (Pharmacokinetic study)
Result:Moderate clearance (28 mL/min/kg) in mice with good oral bioavailability (F% 34), and showed remarkably low plasma protein binding in mice (40%).
IC 50KDM5
References[1] Liang J, et al. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. Bioorg Med Chem Lett. 2017 Jul 1;27(13):2974-2981. DOI:10.1016/j.bmcl.2017.05.016
KDM5A-IN-1 Preparation Products And Raw materials
Tag:KDM5A-IN-1(1905481-36-8) Related Product Information
5-Carboxy-8-hydroxyquinoline Deferiprone GSK-LSD1 Dihydrochloride 3-Acridinecarboxamide, 9-chloro-5,6,7,8-tetrahydro-N-[(4S)-5-[4-hydroxy-4-[[7-[[3-(4-methyl-1-piperazinyl)-1-oxopropyl]amino]-4-oxo-3(4H)-quinazolinyl]methyl]-1-piperidinyl]-5-oxo-4-(phenylmethyl)pentyl]- SP2509 Tranylcypromine Hemisulfate